Influenza A virus
The type species of the genus ALPHAINFLUENZAVIRUS that causes influenza and other diseases in humans and animals. Antigenic variation occurs frequently between strains, allowing classification into subtypes and variants. Transmission is usually by aerosol (human and most non-aquatic hosts) or waterborne (ducks). Infected birds shed the virus in their saliva, nasal secretions, and feces.
Subtype terms (17)
More specific conditions that are subtypes of Influenza A virus in the MeSH hierarchy.
- Influenza A Virus, H10N7 Subtype
- Influenza A Virus, H10N8 Subtype
- Influenza A Virus, H1N1 Subtype
22 drugs (13 approved, 9 experimental)
- Influenza A Virus, H1N2 Subtype
- Influenza A Virus, H2N2 Subtype
- Influenza A Virus, H3N2 Subtype
4 drugs (1 approved, 3 experimental)
- Influenza A Virus, H3N8 Subtype
- Influenza A Virus, H5N1 Subtype
12 drugs (3 approved, 9 experimental)
- Influenza A Virus, H5N2 Subtype
1 drug experimental
- Influenza A Virus, H5N6 Subtype
- Influenza A Virus, H5N8 Subtype
- Influenza A Virus, H7N1 Subtype
- Influenza A Virus, H7N2 Subtype
- Influenza A Virus, H7N3 Subtype
- Influenza A Virus, H7N7 Subtype
1 drug approved
- Influenza A Virus, H7N9 Subtype
8 drugs (2 approved, 6 experimental)
- Influenza A Virus, H9N2 Subtype
Drugs by status
Approved for this indication (1)
Phase 4 trials (2)
Phase 3 trials (25)
- phenylephrine
- methylprednisolone
- vitis vinifera
- fexofenadine
- zanamivir
- anti-influenza plasma
- oseltamivir
- acetaminophen
- immune globulin (human)
- ribavirin
- ceftriaxone
- enoxaparin
- danegaptide
- rosehip
- pheniramine
- chlorpheniramine
- clarithromycin
- lansoprazole
- panthenol
- naphazoline
- baloxavir marboxil
- zsp1273
- pimodivir
- favipiravir
- Deunoxavir
Phase 2 trials (17)
Phase 1 trials (12)